Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

NCT01139164 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

78

Enrollment

OTHER

Sponsor class

Stopped Study halted prematurely due to low accrual.

Conditions

Hematological Malignancies

Interventions

DRUG: Regimen A
DRUG: Regimen B
DRUG: Regimen C

Sponsor

Medical University of South Carolina